The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients. We have more ideas, we see more opportunities and we want to help more patients.
In order to achieve this, we will develop Idorsia into one of Europe’s leading biopharmaceutical companies, with a strong scientific core.
Located in Switzerland – a biotech hub of Europe – Idorsia is specialized in the discovery and development of small molecules, to provide innovative therapeutic options.
Find out more about Idorsia's strategy, clinical development pipeline, and the story of how Idorsia was born.
Idorsia has an experienced team of highly qualified professionals who are all reaching out for more.
Idorsia development compounds target a number of different diseases.